The Journal of allergy and clinical immunology

How skin ages and possible targeted treatments

Updated

Abstract

Aging affects human physiology, resulting in reduced organ function and increased susceptibility to chronic diseases.

  • Cellular senescence is a key aspect of aging that connects molecular damage to inflammation, impacting skin structure and function.
  • Chronic inflammation, referred to as inflammaging, may hinder skin regeneration and accelerate aging processes.
  • Advanced skin aging can lead to significant atrophy, chronic fragility, and impaired wound healing.
  • Diminished immunosurveillance in aged skin may increase vulnerability to infections and injuries.
  • Understanding skin aging involves exploring the links between skin health and systemic inflammation, revealing knowledge gaps for future research.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Disclosure statement This work received no funding. Disclosure of potential conflict of interest: E. Guttman-Yassky is an employee of Mount Sinai and has received research grants from and/or is a consultant for Abbvie, Arcutis, Almirall, Amgen, AnaptysBio, Apogee Therapeutics, Apollo Therapeutics Limited, Artax Biopharma Inc, Aslan, Astria, Bristol Meyers Squibb, Boerhinger-Ingelhiem, Calliditas, Cara Therapeutics, Celldex, Centrexion Therapeutics Corporation, Concert, Connect Biopharm, Coty, DBV Technologies, Lilly, Enveda Biosciences, Escient Pharmaceuticals Inc, Fairmount Funds Management LLC, FL2022-001 Inc, Galderma, Gate Bio, GV (Google Ventures), GSK Immunology, Incyte, Inmagene, Janssen Biotech, Jasper Therapeutics, Kymera Therapeutics, Kyowa Kirin, Leo Pharma, Matchpoint Therapeutics, Merck, Nektar Therapeutics, Novartis Pharmaceuticals, Numab Therapeutics AG, Nuvig, OrbiMed Advisors LLC, Otsuka, Pfizer, Pharmaxis Ltd, Pioneering Medicine VII Inc, Proteologix US Inc, Q32Bio, RAPT, RayThera Inc, Regeneron Pharmaceuticals, RibonTherapeutics Inc, Sagimet Biosciences, Sanofi, SATO, Schrödinger Inc, Sitryx, Sun Pharma Advanced Research Company (SPARC), Takeda, Teva Branded Pharmaceutical Products R&D Inc, TRex, UCB, Ventyx Biosciences. The rest of the authors declare that they have no relevant conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free